The prognostic roles of PYCR2 and ZBTB18 expression in tissues of colorectal carcinoma and non-neoplastic tissues: an immunohistochemical study

Harb, Ola A; Elfeky, Mariem A; Wadea, Fady M; Elsayed, Ahmed M; Elshorbagy, Shereen; Amin, Ahmed F; Oraby, Ehab M; Amin, Mohamed Farouk; Almoregy, Abdelwahab S.
J. coloproctol. (Rio J., Impr.) ; 42(3): 193-202, July-Sept. 2022. tab, graf, ilus
Artículo en Inglés | LILACS | ID: biblio-1421988

Documentos relacionados

  1. Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma.
  2. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
  3. LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis.
  4. Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
  5. Constructing and validating a risk model based on neutrophil-related genes for evaluating prognosis and guiding immunotherapy in colon cancer.
  6. Exploring the adaptive leisure activities of classified nursing model in elderly colon cancer patients: a perspective on interactive care.
  7. Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer.
  8. Clinical plasma cells-related genes to aid therapy in colon cancer.
  9. Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer.
  10. Establishment and validation of a prognostic nomogram for patients with early-onset stage I-II colon cancer.